KIRSTI SEMICH: Open Payments
NPI 1881150464 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 31 payments from 16 companies in 2025. Trend: 2023 $893 · 2024 $544 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $95 |
| Neurocrine BioSciences, Inc. | 3 | $86 |
| Novo Nordisk Inc | 3 | $84 |
| PFIZER INC. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| Lundbeck LLC | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Exact Sciences Corporation | 1 | $27 |
Products named: INGREZZA, REXULTI, Ozempic, QULIPTA, XIFAXAN, HETLIOZ, CAPLYTA, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
